Allan M Weissman

Title: Allan M Weissman: Innovator in Cancer Treatment

Introduction

Allan M Weissman is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. With a total of 4 patents, Weissman has focused on creating solutions that enhance the efficacy of cancer therapies.

Latest Patents

Weissman's latest patents include groundbreaking inventions such as highly soluble pyrimido-dione-quinoline compounds. These compounds are designed to improve solubility and are utilized in pharmaceutical compositions aimed at treating cancer. The method involves administering these compounds to patients suffering from cancer, showcasing Weissman's commitment to advancing medical treatments. Another significant patent involves the Ube2G2 binding domain in the ubiquitin ligase gp78. This invention features isolated nucleic acid molecules that encode the binding site from the gp78 ubiquitin ligase, which interacts with the Ube2G2 ubiquitin conjugating enzyme. The patent also provides diagnostic and therapeutic methods, as well as screening assays utilizing these compositions.

Career Highlights

Throughout his career, Weissman has worked with esteemed organizations, including the United States Department of Health and Human Services and Bioveris Corporation. His work in these institutions has allowed him to contribute to significant advancements in health and medicine.

Collaborations

Weissman has collaborated with notable colleagues such as Yili Yang and Jane P Jensen. These partnerships have further enriched his research and development efforts in the field of cancer treatment.

Conclusion

Allan M Weissman is a distinguished inventor whose work has had a profound impact on cancer treatment. His innovative patents and collaborations reflect his dedication to improving patient outcomes through scientific advancements.